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Background: Malaria especially falciparum malaria still causes high morbidity and mortality in tropical countries.
Several factors have been linked to this situation and the most important one is the rapid spread of parasite
resistance to the currently available antimalarials, including artemisinin. Artemisinin is the main component of
the currently recommended antimalarial, artemisinin based combination therapy (ACT), and it is a free radical
generating antimalarial. Garcinia mangostana L (mangosteen) rind contain a lot of xanthone compounds acting
as an antioxidant and exhibited antimalarial activity. The aim of this study was to evaluate the antimalarial activity
of mangosteen rind extract and its fractions and their interaction with artemisinin against the 3D7 clone of
Plasmodium falciparum in vitro.
Methods: Dry ripe mangosteen rind was extracted with ethanol followed by fractionation with hexane,
ethylacetate, buthanol, and water consecutively to get ethanol extract, hexane, athylacetate, buthanol, and water
fractions. Each of these substances was diluted in DMSO and examined for antimalarial activity either singly or in
combination with artemisinin in vitro against Plasmodium falciparum 3D7 clone. Synergism between these
substances with artemisinin was evaluated according to certain formula to get the sum of fractional inhibitory
concentration 50 (∑FIC50).
Results: Analysis of the parasite growth in vitro indicated that IC50 of these mangosteen rind extract, hexane,
ethylacetate, buthanol, and water fraction ranged from 0.41 to > 100 μg/mL. All of the ∑FIC50 were <1.
Conclusions: This study demonstrated a promising antimalarial activity of the extract and fractions of G.
mangostana L rind and its synergistic effect with artemisinin. Further study using lead compound(s) isolated from
extract and fractions should be performed to identify more accurately their mechanism of antimalarial activities.
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Background
Malaria remains a major public health issue worldwide
despite a decreasing trend in its morbidity and mortality
between 2000 and 2015. In 2015, WHO reported 214
million clinical cases with 438.000 death and approxi-
mately 3.3 billion population or half of the world popu-
lation are at risk. Most malaria cases were caused by
Plasmodium falciparum and Plasmodium vivax but
most of the death was caused by Plasmodium falcip-
arum infection [1]. The persistently high morbidity and
mortality of malaria is due to the rapid speed of drug
resistant parasite including the currently used artemisi-
nin combination therapy (ACT) [2].
Artemisinin, the main component of ACT, is a free
radical generating antimalarial [3] that has a short half
life [4–6], and rapidly clear the parasite [7]. Its single
prescription is not recommended due to recrudescence
rate [8], and therefore several partner drugs with longer
half life are now available such as in artemeter-
lumefantrine, dihydroartemisinin-piperaquine, artesunate-
mefloquine, artesunate-amodiaquine. Unfortunately resist-
ance of the parasite to the partner drugs has also been
reported [9–11].
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Xanthones are potent antioxidant [12], and they
possibly reduce the free radical over production in
malaria especially if artemisinin is used to manage the
disease. On the other side, these compounds can also
inhibit heme polymerization [13] that is needed by the
parasite to detoxify the heme over production. Our
previous study revealed that alpha-mangostin and
gamma-mangostin are both xanthone compounds, and
exhibited antimalarial activities with synergistic effect with
artemisinin [14].
Garcinia mangostana L (mangosteen) grows in trop-
ical area [15], where malaria is endemic. Its general
name is mangosteen (English), manggis (Indonesia),
and its taxonomic profile is: Magnoliophyta division,
Magnoliopsida class, Dilleniidae subclass, Theales
order, Clusiaceae family, Garcinia genus, Garcinia man-
gostana L. species. Its rind, usually a waste product,
contained a lot of xanthone compounds [16, 17] and
therefore may be developed as alternative drug to treat
malaria. This study aims to explore the potential of
mangosteen rind as partner drug of artemisinin for
treating malaria.
Methods
Plant collection and preparation
Identification of this plant was done by Mr. Djuandi,
a curator at the Herbarium Bandungense, Sekolah
Tinggi Imu Hayati, Bandung Institute of Technology
(ITB), Bandung, Indonesia. A voucher specimen of
this material has been deposited in a publicly avail-
able herbarium, the Herbarium Bogoriense, Research
Center of Biology, Indonesian Institute of Sciences by
Dr. J S Rahajoe in 2012 with deposition number of
1143/IPH.1.02/lf.8/VII/2012. The fresh ripe G.mangos-
tana L fruit which had purple color was collected
from Subang District, West Java, Indonesia. The fruit
was washed with tap water gently and its rind with-
out kernel and seed inside was carefully analyzed for
debris and content. The rind was cut into small
pieces, air dried, and pulverized into powder. The
powder was then macerated with absolute ethanol
and subsequently evaporated to obtain the paste like
extract according to standard procedure [18]. The
extract was then fractionated using hexane to obtain
hexane fraction following the same procedure [18].
The hexane fraction obtained was then re-fractionated
using ethylacetate to obtain ethylacetate fraction. This
procedure was continued using buthanol and water
consecutively to obtain buthanol and water fraction.
All of these extract and fractions were stored in the -
20 °C freezer until used. To examine the antimalarial
activity, each of these substances was dissolved in
dimethyl sulfoxide (DMSO, Sigma Aldrich, IL, USA)
to make a stock solution separately.
Parasite cultivation and determination of 50% Inhibitory
Concentration (IC50) of G. mangostana L rind extracts,
hexane, ethylacetate, buthanol, and water fractions
against P. falciparum 3D7 clone
To determine the antimalarial activity of these extracts
and fractions, malarial parasites, P. falciparum 3D7
clone was obtained from the Malaria Laboratory, The
Eijkman Institute for Molecular Biology, Jakarta, and
was propagated in vitro in duplicate in a 24 well culture
plate in the presence of a wide concentration ranges of
each extracts and fractions following the procedure
described previously [19]. The Red Blood Cell (RBC)
used for the propagation of the parasites was a left over
or outdated RBC provided by the Indonesian Red Cross,
Surabaya, Indonesia without any personal identity except
for the type of blood. The parasites concentration in
vitro was calculated before and after 48 h incubation
with a wide concentration range of each of the ex-
tracts and fractions by determining the amount of
parasites per 5000 RBC in Giemsa stained thin blood
smear. The parasites growth inhibition was calculated
by comparing the parasites concentrations of the
treated group with the untreated control. The para-
sites IC50 of each of the extracts and fractions was
determined using probit analysis. The antimalarial ac-
tivity was classified following the criteria as describe
previously [20].
Determination of interaction between artemisinin and G.
mangostana L rind extracts, hexane, ethylacetate,
buthanol, and water fractions as antimalarial against P.
falciparum 3D7 clone in vitro
The parasites was cultivated in duplicate in the
presence of a wide concentration range of combin-
ation of artemisinin and each of these extract sand
fractions in 1:1 concentration ratio. The parasites
growth before and after 48 h incubation was evalu-
ated by measurement of the parasites concentration
in Giemsa stained thin blood smear and the growth
inhibition as well as the IC50 was determined using
the aforementioned procedure. Interaction between
artemisinin and each of these extracts and fractions
was determined according to the sum of fractional
50% inhibitory concentration (FIC50) of artemisinin
and each of these extracts and fractions according to
formula: Ac/As + Bc/Bs, where Ac and Bc are the con-
centration of A and B in the combination associated
with a particular level of effect, e.g., IC50, while As
and Bs are the concentration of A and B when are
used singly to produced the same level of effect. If
this sum is 1, the interaction of these drugs is named addi-
tive interaction. Synergistic interaction is named if this
sum is less than 1 and if this sum is more than 1, it is
named antagonistic interaction [21].
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Results
Proximate analysis
Proximate analysis of dry G.mangostana L rind is shown
in Additional file 1. The rind extracts mainly contained
carbohydrate, crude fibre, and ash.
In vitro antimalarial activity of G. mangostana L extracts
and its fractions against 3D7 clone of P. falciparum
The parasites growth in the presence of different
concentration of its extracts, hexane, ethylacetate,
buthanolic, and water fractions is shown in Additional
files 2, 3, 4, 5 and 6 respectively. Analysis of the para-
sites growth revealed that the IC50 of the extracts,
hexane, ethylacetate, buthanolic, and water fractions,
ranged from 0.42 μg/mL (ethanolic extract), 0.12 μg/mL
(hexane fraction), 1–10 μg/mL (ethylacetate fraction),
1152 μg/mL (buthanolic fraction) to > 100 μg/mL
(water fraction).
In vitro interaction between artemisinin and G.
mangostana L rind extract and its fractions as antimalaria
against 3D7 clone of P. falciparum
The parasite growth in the presence of combination of
artemisinin and the extract, hexane, ethylacetate, butha-
nolic, and water fraction is shown in (Additional files 7,
8, 9, 10 and 11). Analysis of the parasite growth revealed
the IC50 ranged from 0,00001 to 0,0001 μg/mL.
Discussion
In vitro antimalarial activity of G.mangostana L rind
extract and its fractions
The present study demonstrates a promising antimalarial
activity of the extract, hexane, and ethylacetate fraction
of the rind of G.mangostana L with the IC50 of less than
10 μg/mL. However, the buthanolic and water fractions
revealed a very weak antimalarial activities. The results
of this study therefore deserves further exploration to
identify the lead compounds that may underline the
antimalarial activity. The G.mangostana L. rind contains
many kinds of phenolic compounds such as tannins,
anthocyanins, xanthones, and their derivates [22–25].
The most abundant xanthones in G.mangostana L. rind
are alpha-mangostin and gamma-mangostin [26]. These
xanthones and other xanthones such as garcinone C and
garcinone D also existed in the rind, and have been
reported to exhibit active antimalarial activities [14].
Therefore we may conclude that the antimalarial activity
exhibited by the rind extract and fractions are caused by
the existence of alpha-mangostin, gamma-mangostin,
garcinone C, and garcinone D in the rind. Further, the
antimalarial activity of xanthones was previously associ-
ated with the interference with the heme polymerizatio-
nin the malarial parasite [13]. It was reported that
xanthones form soluble complex with heme dimmers so
that it increases osmotic pressure in the parasite food
vacuole causing parasite lysis and death [27]. G. mangos-
tana L rind ethanolic extract also interrupts the tricarb-
oxylic acid (TCA) metabolism of the parasite as
indicated by the absence of malate product in the cul-
ture medium [28].
In vitro interaction between artemisinin and G.
mangostana L rind extract and its fractions as antimalaria
against 3D7 clone of P. falciparum
All kinds of combination of the extract and fractions
with artemisinin showed a very strong antimalarial activ-
ity as indicated by the IC50 which was < 0,001 μg/mL
and the sum of FIC50 which was in the range of 0,03 –
0,25, which means synergistic interaction (Additional file
12). Similar finding was also reported in our previous in
vitro study using pure compounds of alpha-mangostin,
gamma-mangostin, garcinone C and garcinone D [14].
Other in vitro study also demonstrated that the synergis-
tic effect between hydroxycalabaxanthone and artesunate
[29]. As the studies using the relatively pure compounds,
we therefore could suggest that the synergistic antimal-
arial activity exhibited in our study using extract and
fractions are caused by the existence of similar
compounds.
Conclusion
This study demonstrated a promising antimalarial activ-
ity and its synergistic antimalarial activity of the extract
and fractions of G.mangostana L rind with artemisinin.
Further study using lead compound(s) isolated from
extract and fractions should be performed to identify
more accurately their mechanism of antimalarial activities.
Additional files
Additional file 1: Table S1. Proximate analysis of G. mangostana L rind.
(DOC 29 kb)
Additional file 2: Table S2. Parasite growth and inhibition rate in
G.mangostana L rind extract treatment in vitro. (DOC 41 kb)
Additional file 3: Table S3. Parasite growth and inhibition rate in
G.mangostana L rind hexane fraction treatment in vitro. (DOC 41 kb)
Additional file 4: Table S4. Parasite growth and inhibition rate in
G.mangostana L rind ethylacetate fraction treatment in vitro. (DOC 40 kb)
Additional file 5: Table S5. Parasite growth and inhibition rate in
G.mangostana L rind buthanol fraction treatment in vitro. (DOC 41 kb)
Additional file 6: Table S6. Parasite growth and inhibition rate in
G.mangostana L rind water fraction treatment in vitro. (DOC 40 kb)
Additional file 7: Table S7. Parasite growth and inhibition rate in
G.mangostana L rind extract + artemisinin treatment in vitro. (DOC 42 kb)
Additional file 8: Table S8. Parasite growth and inhibition rate in
G.mangostana L rind hexane fraction + artemisinin treatment in vitro.
(DOC 42 kb)
Additional file 9: Table S9. Parasite growth and inhibition rate in
G.mangostana L rind ethylacetate fraction + artemisinin treatment in
vitro. (DOC 42 kb)
Tjahjani BMC Complementary and Alternative Medicine  (2017) 17:131 Page 3 of 5
Additional file 10: Table S10. Parasite growth and inhibition rate in
G.mangostana L rind buthanolic fraction+ artemisinin treatment in vitro.
(DOC 42 kb)
Additional file 11: Table S11. Parasite growth and inhibition rate in
G.mangostana L rind water fraction + artemisinin treatment in vitro.
(DOC 42 kb)
Additional file 12: Table S12. Interaction between artemisinin and G.
mangostana L rind extract and its fractions as antimalaria against 3D7
clone of P. Falciparum in vitro [30]. (DOC 30 kb)
Abbreviations
ACT: Artemisinin based combination therapy; DMSO: Dimethylsulfoxide;
FIC50: Fractional 50% inhibitory concentration; IC50: 50% inhibitory
concentration; TCA: Tricarboxylic acid cycle
Acknowledgements
The financial support of the Directorate General of Higher Education of Indonesian
Ministry of Education is gratefully acknowledged. The author thank to Prof.dr.
Syafruddin, Ph.D. from Eijkman Institute-Jakarta who provided the writing advice
and to Wiwied Ekasari, Ph.D as a Coordinator of Malaria Laboratory, Airlangga
University, Surabaya, who provided the technical support.
Funding
This study was fully financially supported by the Directorate General of
Higher Education of Indonesian Ministry of Education.
Availability of data and materials
All data generated or analysed during this study are included in this
published article [and its Additional files].
Authors’ information
As the author, I am chairing the Bandung Indonesian Parasitic Disease
Control Association, work as a lecturer and Tropical Disease Coordinator of
Medical Research Centre at Faculty of Medicine, Maranatha Christian
University, Bandung, Indonesia.
Competing interests
I as the author declare that there are no competing interests.
Consent for publication
This consent was not relevant for this sudy.
Ethics approval and consent to participate
This study has been approved by dr. Diana Krisanti Jasaputra, Ph.D. and
Wahyu Widowati, Ph.D as Ethic Committee of Faculty of Medicine,
Maranatha Christian University-Immanuel Hospital Bandung. Consent to
participate was not relevant for this study.
Received: 14 September 2016 Accepted: 23 February 2017
References
1. World Malaria Report WHO. 2015. Available from http://www.who.int/malaria/
publications/world-malaria-report-2015/report/en/. Accessed 2 Aug 2016.
2. WHO. Antimalarial drug resistance. Available from http://www.who.int/
malaria/areas/drug_resistance/overview/en/. Accessed 2 Aug 2016.
3. Antoine T, Fisher N, Amewu R, O’Neill PM, Ward SA, Biagini GA. Rapid kill of
malaria parasites by artemisinin and semi-synthetic endoperoxides involves
ROS-dependent depolarization of the membrane potential. J Antimicrob Chemother.
2014;69(4):1005–16.
4. Ilett KF, Batty KT, Powell SM, Tran QB, Le TAT, Hoang LP, et al. The pharmacokinetic
properties of intramuscular artesunate and rectal dihydroartemisinin in
uncomplicated falciparum malaria. Br J Clin Pharmacol. 2002;53(1):23–30.
5. Nealon C, Dzeing A, Müller-römer U, Planche T, Sinou V, Kombila M,
et al. Intramuscular bioavailability and clinical efficacy of artesunate in gabonese
children with severe Malaria. Antimicrob Agents Chemother. 2002;46(12):3933–9.
6. Karbwang J, Na-Bangchang K, Tin T, Sukontason K, Rimchala W, Harinasuta
T. Pharmacokinetics of intramuscular artemether in patients with severe
falciparum malaria with or without acute renal failure. Br J Clin Pharmacol.
1998;45(6):597–600.
7. Linares M, Viera S, Crespo B, Franco V, Gómez-Lorenzo MG, Jiménez-Díaz MB,
et al. Identifying rapidly parasiticidal anti-malarial drugs using a simple and
reliable in vitro parasite viability fast assay. Malar J [Internet]. 2015;14(1):441.
Available from: http://www.malariajournal.com/content/14/1/441.
8. Giao PT, Binh TQ, Kader PA, Long HP, Van Thang N, Van Nam N, et al.
Artemisinin for treatment of uncomplicated falciparum malaria : is there a
place for monotherapy ? Am J Trop Med. 2001;65(6):690–5.
9. Amaratunga C, Lim P, Suon S, Sreng S, Mao S, Sopha C, et al. Dihydroartemisinin-
piperaquine resistance in Plasmodium falciparummalaria in Cambodia: A multisite
prospective cohort study. Lancet Infect Dis [Internet]. 2016;16(3):357–65.
Available from: http://dx.doi.org/10.1016/S1473-3099(15)00487-9.
10. Färnert A, Ursing J, Tolfvenstam T, Rono J, Karlsson L, Sparrelid E, et al.
Artemether-lumefantrine treatment failure despite adequate lumefantrine day
7 concentration in a traveller with Plasmodium falciparum malaria after
returning from Tanzania. Malar J [Internet]. 2012;11(1):176. Available from:
https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-11-176.
11. Tun KM, Jeeyapant A, Imwong M, Thein M, Aung SSM, Hlaing TM, et al.
Parasite clearance rates in Upper Myanmar indicate a distinctive artemisinin
resistance phenotype: a therapeutic efficacy study. Malar J [Internet]. 2016;
15(1):185. Available from: http://malariajournal.biomedcentral.com/articles/
10.1186/s12936-016-1240-7.
12. Zarena AS, Sankar KU. Screening of xanthone from mangosteen (Garcinia
mangostana L.) peels and their effect on cytochrome c reductase and
phosphomolybdenum activity. J Nat Prod. 2009;2:23–30.
13. Ignatushchenko MV, Winter RW, Riscoe M. Xanthones as antimalarial agents:
stage specificity. Am J Trop Med Hyg. 2000;62(1):77–81.
14. Tjahjani S, Widowati W. Potensi beberapa senyawa xanthone sebagai
antioksidan dan anti-malaria serta sinergisme dengan artemisinin in Vitro.
Indonesian Med J. 2013;63(3):95–9.
15. Morton JF. Mangosteen. In: Morton JF. Fruits of Warm Climates. 2004. 1439–
1446. Available from http://www.pssurvival.com/ps/plants/Crops_Fruits_Of_
Warm_Climates_2004.pdf. Accessed 2 Aug 2016.
16. Pedraza-Chaverri J, Rodríguez NC, Ibarra MO, Rojas JMP. Medicinal properties
of mangosteen (Garcinia mangostana). Food Chem Toxicol. 2008;46:3227–39.
17. Zhang Y, Song Z, Hao J, Qiu S, Xu Z. Two new prenylated xanthones and a
new prenylated tetrahydroxanthone from the pericarp of Garcinia
mangostana. Fitoterapia. 2010;81(6):595–9.
18. Mahdi S, Altikriti Y. Extraction of Natural Products. Sweden: Biologiskt Aktiva
Natuprodukter, Uppsala University; 2010. http://www.fkog.uu.se/course/a/biolakt/
biolakt-archive/BiolAkt%202010-2/StudentpresentationerHT2010%20(kopia)/
BiolAktHT2010_ExtraktionNatProd_Yassir_Suzan/Extraction%20of%20natural%
20products_files/Page470.htm. Accessed 27 July 2016.
19. Budimulja AS, Syafruddin D, Tapchaisri P, Wilariat P, Marzuki S. The sensitivity
of Plasmodiumprotein synthesis to prokaryotic ribosomal inhibitors. Mol Biochem
Parasitol. 1997;84:137–41.
20. Ramalhete C, Lopes D, Mulhovo S, Rosario VE, Ferreira MJU. Antimalarial
activity of some plants traditionally used in Mozambique. Workshop Plantas
Medicinais e Fitoterapeuticas nos Tropicos. IICT/CCCM, 29, 30 e 31 de
Outubro de 2008. Available from http://www2.iict.pt/archive/doc/C_
Ramalhete_wrkshp_plts_medic.pdf. Accessed 3 Aug 2016.
21. Nandakumar DN, Arun V, Vathsala PG, Rangarajan P, Nandakumar DN,
Nagaraj VA, et al. Curcumin-artemisinin combination therapy for malaria.
Antimicrob Agents Chemother. 2006;50(5):1859–61.
22. Maisuthisakul P, Suttajit M, Pongsawatmanit R. Assessment of phenolic
content and free radical scavenging capacity of some Thai indigenous
plants. Food Chem. 2007;100:1409–18.
23. Setyawati NA. Pengaruh perendaman konsentrasi larutan kapur tohor
terhadap efektifitas netralisasi rasa pahit pada produk jelly kulit buah
manggis. Thesis. Fakultas Teknik, UNNES, Semarang, Indonesia. 2000.
24. Fu C, Loo AEK, Chia PP, Huang D. Oligomeric proanthocyanidins from
mangosteen pericarps. J Agric Food Chem. 2007;55:7689–94.
25. Pebriyanthi NE. Ekstraksi xanthone dari kulit buah manggis (Garcinia mangostana L.)
dan aplikasinya dalam bentuk sirup. Skripsi. Fakultas Teknologi Pertanian, Institut
Pertanian Bogor, Bogor, Indonesia. 2010.
26. Walker EB. HPLC analysis of selected xanthones in mangosteen fruit.
J Sep Sci. 2007;30:1229–34.
27. Riscoe M, Kelly JX, Winter R. Xanthones as antimalarial agents: discovery,
mode of action, and optimization. Curr Med Chem. 2005;12:2539–49.
28. Chaijaroenkul W, Mubaraki MA, Ward SA, Na-Bangchang K. Metabolite
footprinting of Plasmodium falciparum following exposure to Garcinia
mangostana Linn. crude extract. Exp Parasitol. 2014;145:80–6.
Tjahjani BMC Complementary and Alternative Medicine  (2017) 17:131 Page 4 of 5
29. Chaijaroenkul W, Na-Bangchang K. The in vitro antimalarial interaction of
9-hydroxycalabaxanthone and α mangostin with mefloquine/artesunate.
Acta Parasitol. 2014;60(1):105–11.
30. Tjahjani S. Effect of L-ascorbic acid against host cell and antimalarial activity
of artemisinin using MDA and GSH concentration, HUVEC viability, and
parasitemia level as parameters. Dissertation. Faculty of Medicine, University
of Padjadjaran, Bandung, Indonesia. 2008.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Tjahjani BMC Complementary and Alternative Medicine  (2017) 17:131 Page 5 of 5
